Viewing nowLopirel Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201306377 · Approved 2013.03.22 · Insurance code 648602500
Improvement of atherosclerotic symptoms such as ischemic stroke and myocardial infarction, and reduction of the risk of stroke and thromboembolism
This medication is helpful in improving symptoms in adult patients with atherosclerotic symptoms such as ischemic stroke, myocardial infarction, and peripheral arterial disease. It is also used to improve cardiovascular complications (such as myocardial infarction and stroke) in patients with acute coronary syndrome, particularly those with unstable angina or non-Q-wave myocardial infarction who are receiving or will receive drug treatment, coronary interventional procedures, or coronary artery bypass surgery. Additionally, it is effective in reducing the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors and where vitamin K antagonists are not suitable and the bleeding risk is low. This medication aids in reducing major cardiovascular risks and preventing thrombosis, thereby improving the patient's health status.
For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, the recommended oral dose of Clopidogrel is 75 mg once daily. For patients with acute coronary syndrome, begin with a loading dose of 300 mg once daily on the initiation day and maintain with 75 mg once daily thereafter. Aspirin 75 to 325 mg must be given once daily in conjunction at this time. For patients with atrial fibrillation, the recommended oral dose is 75 mg once daily.
This medication is designed to prevent platelets in the blood from aggregating, thereby preventing the formation of blood clots. This medication must be converted to its active form in the liver for effectiveness; thus, individuals with genetically reduced function of the liver enzyme CYP2C19 may experience weakened efficacy. Therefore, in such cases, it is necessary to consult with a physician to adjust the treatment approach or to switch to another medication. Moreover, concomitant use with other medications that activate the CYP2C19 enzyme may increase the active ingredient concentration of this medication and elevate the risk of bleeding, so combination should be avoided. Patients who have allergies to this medication, those with severe bleeding, severe liver diseases, breastfeeding women, and those with lactose intolerance should not take this medication. If symptoms of bleeding occur during treatment, immediate consultation with a doctor is essential, especially for patients at risk of bleeding in delicate areas such as the gastrointestinal tract, brain, and eyes. Concomitant use with other platelet inhibitors or anticoagulants such as aspirin may further increase the risk of bleeding, thus caution is advised. Patients scheduled for surgery should discontinue use of this medication 5–7 days prior to the surgery and recommence only after hemostasis is achieved. This medication may rarely cause hematologic adverse reactions such as thrombocytopenia and neutropenia, so it is imperative to seek immediate consultation with a physician if symptoms of fever or infection arise. Mild side effects such as dyspepsia, diarrhea, headache, and rash may occur, and in cases of severe bleeding or allergic reactions, immediate medical attention is necessary. The risk to the fetus during pregnancy is not clearly defined, however, treatment should not be delayed for those with cardiovascular and cerebrovascular diseases, and caution is warranted as the risk of bleeding may increase during delivery. In breastfeeding cases, as this medication may be secreted into breast milk, the option to either cease breastfeeding or to discontinue the medication should be chosen. Elderly individuals or patients with impaired kidney or liver function are at increased risk of bleeding, hence careful observation and dosage adjustment should be undertaken. In cases of overdose, the risk of bleeding increases, and since there is no specific antidote, treatment such as platelet transfusion may be required in cases of severe bleeding. Store the medication out of reach of children and do not transfer it to another container. During treatment, any new medication initiation or surgery should be communicated to healthcare providers and any symptoms of bleeding should be reported immediately.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash accompanied by high fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and extremely severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination issues
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it at a temperature between 1 to 30 degrees Celsius. Storing it this way preserves the medication's effectiveness and prevents deterioration.
Pink round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.